• In the ’60’s Dotter used serial dilators to perform angioplasty.
  • In  the ’70’s Gruntzig developed the angioplasty balloon catheter.
  • In the ’80’s Simpson improved Gruntzig’s angioplasty balloon catheter by allowing it to be passed over a guidewire.
  • After 40 years Summa introduces perhaps the last significant evolution of the angioplasty balloon:  the Finesse Injectable Angioplasty Balloon CatheterTM.


The Finesse Injectable Angioplasty Balloon CatheterTM allows contrast or medications to be injected with the guidewire in place, exiting a port 8 cm proximal to the balloon.  Injectability is designed to reduce catheter exchanges during complex below-the-knee interventions by enabling arteriography to be done using the angioplasty balloon catheter, over the wire.  Fewer catheter exchanges can contribute to quicker procedures, improved patient comfort, and reduced equipment and room time costs.

Finesse is a hybrid catheter:  a 4.7 Fr proximal catheter that tapers to a 2.9 Fr distal segment, combining the pushability of an 0.035″ platform with the trackability of a 0.014.


Indicated for arterial angioplasty, FinesseTM is the only injectable small vessel PTA catheter on the market.  FinesseTM is FDA cleared for for Percutaneous Transluminal Angioplasty (PTA) in the peripheral vasculature, including popliteal, infra-popliteal and renal arteries, as well as arteriovenous dialysis fistulae. Finesse™ features a semi-compliant balloon cleared in 4 diameters, ranging from 2.5 to 4.0 mm with rated burst pressures up to 14 atm.